Why Sol-Gel Technologies Ltd.’s (SLGL) Stock Is Down 6.67%
As of Friday, October 16, Sol-Gel Technologies Ltd.’s SLGL share price has dipped by 6.67%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Commentary & Analysis
Why Sol-Gel Technologies Ltd.’s (SLGL) Stock Is Down 6.32%
As of Thursday, October 08, Sol-Gel Technologies Ltd.’s SLGL share price has dipped by 6.32%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Sol-Gel Technologies Ltd.’s (SLGL) Stock Is Up 6.25%
As of Monday, October 05, Sol-Gel Technologies Ltd.’s SLGL share price has surged by 6.25%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Sol-Gel Technologies Ltd.’s (SLGL) Stock Is Up 6.75%
As of Monday, September 28, Sol-Gel Technologies Ltd.’s SLGL share price has surged by 6.75%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Sol-Gel Technologies Ltd.’s (SLGL) Stock Is Up 5.47%
As of Tuesday, September 22, Sol-Gel Technologies Ltd.’s SLGL share price has surged by 5.47%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | SLGL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $221.7 | $470.3 | 29% |
|
| Shares Out (Mil) | 3.3 | 43.4 | 11% |
|
| Institutional Ownership | 17.4% | 81.3% | 9% |
|
| Float (Mil) | 0.5 | 46.8 | 1% |
|
| Beta | 1.16 | 0.71 | 68% |
|
| Avg Daily Volume (000s) | 39 | 279 | 27% |
|
| Price Change (52-week) |
83.0% | 54.1% | 93% |
|
| Growth | SLGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 17.1% | 6.1% | 77% |
|
| Net Income (5yr) | 26.9% | (2.4%) | 82% |
|
| EPS (5yr) | 29.9% | 14.9% | 81 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (35.6%) | (15.1%) | 15% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 4 | |
| Current EPS | ($2.073) | ($7.750) | ($8.033) | |
| Month Ago EPS | ($3.010) | ($11.780) | ($8.373) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | ($2.580) | ($8.318) | ($8.145) | |
| Year/Year Chg | 84.1% | 252.4% | 227.4% | |
| Financials | SLGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2 | $335 | 3% |
|
| Net Income (TTM) (Mil) | ($16) | ($11) | 25% |
|
| EPS (TTM) | ($5.593) | ($0.700) | 7% |
|
| Operating Cash Flow (TTM) (Mil) | na | ($6) | na |
|
| Net Cash Flow (TTM) (Mil) | na | $4 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $6 | 13% |
|
| Enterprise Value (Q1) (Mil) | $206 | $493 | 26% |
|
| Valuation | SLGL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.61 | 2.17 | 78% |
|
| P/E | na | 17.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | SLGL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (781.3%) | 69.4% | 0% |
|
| Net Margin | (910.1%) | 3.3% | 0% |
|
| ROA | (34.1%) | (21.8%) | 15% |
|
| ROE | (39.4%) | (21.0%) | 18% |
|
| Liabilities to Assets | 10.5% | 31.8% | 6% |
|
| F-Score | 2 | 3 | 7% |
|
Sol-Gel Technologies Ltd. did not pass any screens on 10/30/2026.
